JPRN-UMIN000030582
Completed
未知
Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trial - Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer: a randomized controlled phase III trial
Tokyo Metropolitan Hiroo Hospital0 sites160 target enrollmentDecember 26, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tokyo Metropolitan Hiroo Hospital
- Enrollment
- 160
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) absence of informed consent 2\) patients who doctors find unsuited 3\) patients with bleeding after surgery 4\) patients with preoperative anticoagulant therapy 5\) patients with allergy for heparin 6\) patients with acute bacteria endocarditis 7\) severe renal dysfunction (Ccr\<30ml/min) 8\) patients with deep venous thrombosis at preoperative ultrasonography
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
ow-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different dosesPrevention of thromboembolic events in hospitalised COVID-19 infected patientsMedDRA version: 20.0Level: HLGTClassification code 10014523Term: Embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-001709-21-FRCHRU de Nancy550
Not yet recruiting
Phase 4
A study to determine effectiveness of Low Molecular Weight Heparin in reduction ofseverity of Acute PancreatitisHealth Condition 1: K859- Acute pancreatitis, unspecifiedCTRI/2022/12/048036Jawaharlal Institute of Postgraduate Medical Education and Research
Completed
Phase 4
Highlow study: Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two dosesNL-OMON55412Academisch Medisch Centrum200
Active, not recruiting
Phase 1
Highlow study:Prevention of recurrent deep vein thrombosis and lung embolism in pregnant womeEUCTR2012-001505-24-IEThe Rotunda Maternity Hospital850
Active, not recruiting
Phase 1
Highlow study:Prevention of recurrent deep vein thrombosis and lung embolism in pregnant womedeep vein thrombosispulmonary embolismMedDRA version: 18.0Level: LLTClassification code 10066529Term: Deep vein thrombosis recurrentSystem Organ Class: 100000004866MedDRA version: 18.0Level: LLTClassification code 10066738Term: Recurrent pulmonary embolismSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2012-001505-24-BEAcademic Medical Center850